High-Dose Chemotherapy with Autologous Stem Cell Transplant

Known as: HDC/ASCT, High-Dose Chemotherapy with Stem Cell Support 
Treatment with chemotherapy drugs at levels that will also destroy the bone marrow, followed by infusion of stem cells to reconstitute the immune… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Background:Cardiorespiratory fitness as measured by peak oxygen consumption (VO2peak) is a strong predictor of longevity and may… (More)
  • figure 1
  • table 1
  • table 1
  • figure 2
  • table 2
Is this relevant?
Review
2013
Review
2013
Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoid malignancy in adults accounting for 31% of all NHL in Western… (More)
Is this relevant?
2012
2012
Pneumonitis is a complication of high-dose chemotherapy and autologous stem cell transplant (HDC-ASCT) regimens containing BCNU… (More)
Is this relevant?
2007
2007
OBJECTIVES Angioimmunoblastic T-cell lymphoma (AIL) is a rare lymphoma with a poor prognosis and no standard treatment. Here, we… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
2007
2007
Most patients with Hodgkin lymphoma (HL) are cured with first and second-line treatment; however, the outcome is unknown for… (More)
Is this relevant?
2006
2006
To determine the role of high-dose chemotherapy and autologous stem cell transplantation (HDC/ASCT) in extranodal NK/T-cell… (More)
  • table 1
  • table 3
  • table 2
  • figure 1
  • figure 3
Is this relevant?
Highly Cited
2003
Highly Cited
2003
BACKGROUND T-cell immunophenotype constitutes an unfavorable prognostic factor in aggressive non-Hodgkin's lymphomas. High-dose… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2003
Highly Cited
2003
PURPOSE To evaluate the role of early intensification with high-dose therapy (HDT) and autologous stem-cell transplantation (ASCT… (More)
Is this relevant?
2003
2003
BACKGROUND AND OBJECTIVES Patients with aggressive non-Hodgkin's lymphomas (NHL) who do not obtain a complete response (CR) after… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
Is this relevant?
1998
1998
Ninety-four patients underwent high-dose chemotherapy with stem cell support for stage IV breast cancer. The high-dose… (More)
  • table 1
  • figure 1
  • figure 2
Is this relevant?